Nancy Speck, PhD, Professor of Cell and Developmental Biology, has been appointed Co-Leader of the Abramson Cancer Center's Hematologic Malignancies Program. Dr. Speck will join Ed Stadtmauer, MD effective October 1. Dr. Speck is highly qualified to take on this leadership position, having served as the Associate Director for Basic Science at the Norris Cotton Cancer Center from 2002 - 2008, where she held the James J. Carroll Chair of Oncology before her recruitment to the University of Pennsylvania in 2008. Dr. Speck is an established investigator studying the genes that are required for blood cell formation and function and the mutations occurring leading to human leukemia.
Katherine (Kate) Nathanson, MD, Associate Professor of Medicine in the Division of Translational Medicine and Human Genetics, has been appointed Co-Leader of the Abramson Cancer Center's Cancer Control Program. Dr. Nathanson will join Dr. Katrina Armstrong as Co-Leader effective October 1. Dr. Nathanson is a cancer geneticist internationally recognized for both her clinical and research expertise. Her research focusing on both inherited susceptibility to cancer - breast and testicular - and combining somatic genetic characterization with pre-clinical studies - melanoma and renal cancers - makes her an ideal appointment to this position.